# Effect of Zoledronic Acid on Chemotherapy Induced Bone Loss

> **NCT00352846** · PHASE3 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 135 (actual)

## Conditions studied

- Non-Hodgkin's Lymphoma
- Lymphoma

## Interventions

- **DRUG:** Zoledronic Acid
- **DRUG:** Vitamin D
- **DRUG:** Calcium Carbonate

## Key facts

- **NCT ID:** NCT00352846
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 135 (ACTUAL)
- **Last updated:** 2013-07-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00352846

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00352846, "Effect of Zoledronic Acid on Chemotherapy Induced Bone Loss". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00352846. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*